Member Info for skid35

By more of the same, I hope we're looking at a different outcome from substantially the same strategy as the market / relationships build.
As you say though anyone who has been here a length of time is tired of waiting for the real breakthrough, a few glimpses of possibility but not enough correctly for the market and share price.

Chat is still at the same overall level but has gone elsewhere from this board, as ETH the more bullish / outlandish going to advfn and the more reasonable offline elsewhere. Still a lot of interest amongst the long suffering, patient investors.

ENET do have a salesforce, but due to size and tech not in the traditional sense as a standard company with blokes in navy suits. Interesting comment on an agreement on a US go to market.

You cannot simply change management here, and investment in ENET is essentially an investment in them (especially DL) as individuals. IP is only worth something if it is aligned to the talent who understand it. Even a takeover would have a 12 month earnout.

Going in the right direction if you turn the graph 90 degrees anti clockwise.

Current cash conversion cycle is an incredible c 2 1/2 years, and it that time they provision stock that has no value and debtors who won't pay along the way. An mba study on how not to manage cash and a balance sheet.

Imara up 35% in US but only 1% of nav.

Dryland.
I have been following IIG for sometime, primarily because it has an interest in a private company which I know very well.
Share price reflects similar although different companies, see molten or augmentum. a lot of froth at ipo, Unsure of the discount to nav at the moment but must be getting wider. I see the prime reason for the company is for the directors to use it as an investment vehicle for companies they have a long term vision for, if you're lucky enough to be above water one just to tuck away but as a very small element of your portfolio.

Really difficult to "read" the results against the revised go to market, no real like for like comparison.
Elephant in the room is the option for further investment into Ard.

I have a no cost holding after top slicing. Of course it can go down but I think a good place to park cash, as you say 1. Backed by cash 2. Conservative valuation 3. Pharma / biotech market low so POP element has opportunity to gain. Interesting they are not listing the 12 companies in the POP.

I think you need to do bit of research, he is not a city boy.

Current orders to the end of this year. To secure supply for 23 a new order really needs to be in october.
Price per unit, quantity, margin, total value and time period to which it relates ? Unsure the RNS will provide this level of detail when it comes.
Unsure to what extent built into the share price, need a few more rnss to get the price rolling and 5g cleared out.

Guys like Leahy are rich for a reason, this isn’t spare money he expects to play with and lose. He will have done tonnes of research and, more importantly he will have tested the character / skills / trustworthiness of the management team. A key difference to us more normal folk is I would expect him to have a 5 year plus time horizon here.
Not a holder at the moment, but would like to start building a holding fund permitting.

It does really grate when he sits there all suited and booted talking complete #### in the staged proactive interviews. It's. It's more his calm persona when there is a permanent fire in the background and he simply doesn't see it.
Would love to go to an AGM and ask some real questions.

Due to size will always over react upside and downside but someone still buying. Best performer in my portfolio this year, but to be frank that's not hard !

Bid. Competition always intense in tech, but best tech doesn't always win. Interesting that other companies are mentioned here especially amd. A lot of news on Intel in this space recently who basically are the IP in servers, and no news on these relationships developing from ENET. Hopefully embedded somewhere, or outside the box in the stack, news (as always) would be great.

As a long termer the next quarter has always been the make or break quarter or half year, yet we limp on.
Still waiting for the killer product, high margin and at volume - together with a portfolio of other products.
As you say orders and $$ to get the share price moving and 5G cleared out.

Must say disappointed in the chairman here, had a decent cv and thought he would add control and commercial nous. Unfortunately not, Basu still seems to rule the roost.

Interesting macro environment for the company.
- Will be very weak spending on discretionary items, but distil at better price points than man y.
- High interest rates and construction costs on whisky joint venture
- Thick lizzie trashing sterling hopefully helps exports

Sold out a long time ago now, purely due to a lack of integrity from moon on options re pricing. Still have this on my watch list.
Sad to see where this is as the products are world class, but when every decision revolves around moon thinking "what's in it for me" strategy and operational excellence takes second place.

The levels of transparency here is zero. Over what time period, what strike price, what performance criteria etc - we have seen option a in OPTI be torn up and we priced after they failed to achieve so SOH has history here.
The more I look at this the more I see it as a cash machine for SO H and his family / close mates at the expense of shareholders.

Aquae.
IAS 28 and IFRS 11 (accounting standards), all around significant influence that a shareholder exerts usually considered 20%.